Skip to content

Author

Chin H. Toh

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Germline PALB2-mutated triple negative breast cancer treated with Olaparib in a kidney transplant patient

Olaparib, a poly(ADP-ribose) polymerase inhibitor, is a commonly used agent in the treatment of human epidermal growth factor receptor 2–negative metastatic breast cancer carrying germline BRCA1/2 pathogenic variants. Phase II evidence has demonstrated antitumor activity in patients with partner and localizer of BRCA2...

Gabriel Ci En Loke, Chin H. Toh, S. Liew et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.